North America Analysis
Home Search

medicine management - search results

If you're not happy with the results, please do another search
Health, prevention and long-term care

Health, prevention and long-term care in Germany

The background of Jens Spahn, Germany’s Federal Minister of Health is examined here, plus the wider work of the Federal Ministry of Health concerning health, prevention and long-term care.
future of healthcare

Blockchain: healthcare’s next frontier, or so much hype?

DataArt's Denis Baranov discusses how blockchain is likely to have a significant impact on the future of healthcare
globe

Diabetes: A Global Health Challenge

Professor Nam H. Cho, President of the International Diabetes Federation (IDF) shares his expert views on the rise of diabetes across the globe 
Muscular dystrophy

Muscular dystrophy: Present concerns and foreseen opportunities

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
Bayesian Networks

How Bayesian Networks are pioneering the ‘smart data’ revolution

Norman Fenton and Martin Neil ask what next after ‘big data’, focussing on how Bayesian Networks are pioneering the ‘smart data’ revolution
therapies for Huntington’s disease

Sources of funding in the development of therapies for Huntington’s disease

Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Diabetes & peripheral arterial disease

Diabetes & peripheral arterial disease

A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna

The illusion of cancer and death: Illusion of the self

Sumith A Kularatne, PhD, discusses his thoughts on the illusion of cancer and death
Antimicrobial resistance

Antimicrobial resistance (AMR): Why Europe still needs to talk about a preventable crisis

Michele Calabro’, European Health Management Association Policy and Communications Manager explains antimicrobial resistance (AMR), focussing on why Europe still needs to talk about a preventable crisis that could cause more deaths than cancer
wildfires

The potential long-term environmental health consequences of urban wildfire debris

Birgit Puschner and Pamela Lein from the University of California, Davis share their expert views on the impacts of urban wildfire on chemical contamination in small backyard agriculture.
Clostridium difficile

Treatment of Clostridium difficile associated diseases: One not so small step more… but still,...

Prof Colin J Suckling from the University of Strathclyde provides his seasoned opinion on a front-runner antibiotic for the treatment of Clostridium difficile associated diseases.
Multiple treatments

Evaluating multiple treatments within one study: Some practical considerations

Prof Thomas Jaki, Professor of Statistics at Lancaster University’s Medical and Pharmaceutical Statistics Research Unit tells us about some practical considerations around evaluating multiple treatments for patients.
biomarker

Acute respiratory distress syndrome – diagnostics and therapeutics

Cecilia Van Cauwenberghe, from TechVision Group, Frost & Sullivan provides a detailed analysis of acute respiratory distress syndrome, focussing on the evolving diagnostics and therapeutics in the precision era of medicine.
kidney disease

Caring for our kidneys – findings from the Chronic Kidney Disease (CKD) Audit

The topic of Chronic Kidney Disease (CKD) is placed under the spotlight by experts from the London School of Hygiene and Tropical Medicine, the Primary Care Cardiovascular Society and the charity Kidney Care UK.
shortness of breath

Dyspnea: Shortness of breath

Donald A. Mahler from the Geisel School of Medicine at Dartmouth and Clinical Resource Center of the Alpha-1 Foundation and Valley Regional Hospital, on behalf of the CHEST Foundation, provides an expert view on shortness of breath (dyspnea)
nanomaterials

Nanomaterials in the healthcare sector: The navigation paradox applied to healthcare

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on nanomaterials in today’s healthcare sector, including therapeutic precision versus nanotoxicology risk.
health and social care ecosystem

Nurses in Europe codesigning an EU value-based health and social care ecosystem

Dr Paul De Raeve, Secretary-General of the European Federation of Nurses Associations (EFN) provides an in-depth perspective on the extent to which nurses in Europe are codesigning an EU value-based health and social care ecosystem.
Nanomaterials

Nanomaterials in the semiconductor industry: An end-user industrial perspective

Dr. Dimiter Prodanov from Imec gives an end-user industrial perspective on the vital role of nanomaterials in today’s semiconductor industry and their safe use Nanomaterials are broadly defined as those materials that have a certain percentage of particles at the nanoscale, between 1 and 100 nanometres1. While the size cut-off...
Dyspnoea

Technology interventions to address dyspnoea: Point-of-care lung ultrasonography

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography The Murray and Nadel’s Textbook of Respiratory Medicine (Schwartzstein and Adams, 2016), etymologically defines dyspnoea from the Greek dys (painful, difficult) and pneuma (breath). Clinically, dyspnoea constitutes a medical...
antibiotic

The global challenge of antibiotic resistance

Roxane Feller, AnimalhealthEurope Secretary-General provides a fascinating insight into the global challenge of antibiotic resistance Antibiotics have had very positive effects on animal health over the years. Our pets are living much longer than they were decades ago and livestock are raised much more efficiently through our ability to control...

Follow Open Access Government